Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461824 · ClinicalTrials.gov registry record · Phase 3
Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects
A Phase 3 study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 34
- Enrollment target
NCT01461824: Completed Phase 3 study, sponsored by Nationwide Children's Hospital.
NCT01461824 is a Phase 3 study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 34 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461824, a Phase 3 study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 34 participants
- Enrollment target
Study Summary
The investigators are doing this study to look at how different doses of the Depot medroxyprogesterone acetate (DMPA) shot effect weight gain and bone mineral density in teens. The investigators hope that what the investigators learn from this study will be used to develop ways to keep girls from gaining weight or losing bone density when receiving DMPA.
Primary Outcome
Lumbar spine bone mineral density measured at baseline and 48 weeks. Percent change over this time was calculated.
Interventions
- DRUG Depot medroxyprogesterone acetate (DMPA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-07 |
| Phase | Phase 3 |
What the finished NCT01461824 record still lists
NCT01461824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Depot medroxyprogesterone acetate (DMPA) is the first listed.
NCT01461824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461824 about?
NCT01461824 is a clinical study titled "Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects". The investigators are doing this study to look at how different doses of the Depot medroxyprogesterone acetate (DMPA) shot effect weight gain and bone mineral density in teens. The investigators hope that what the investigators learn from this study will be used to develop ways to keep girls from ga...
What is the current status of trial NCT01461824?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 34 participants. The study started on 2011-09. Estimated completion is 2016-07.
What interventions are being tested in trial NCT01461824?
The interventions under investigation include: Depot medroxyprogesterone acetate (DMPA) (DRUG).
Who is sponsoring clinical trial NCT01461824?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01461824's enrollment target sits among peer trials
34 1905th of 2000 higher than 94 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia